Company intelligence / Profile preview

RD Therapeutics

Ownership: Private
Development stage: Other

Overview

RD Therapeutics applies drug delivery technologies to transform drug release profiles, improving product efficacy and patient convenience. The company focuses on bringing safe, effective, and convenient products to market by combining technological advances with natural resources.

Therapeutic areas: Other
Modalities: Small molecule (through drug delivery technologies)
Industry: Biotech

Drug pipeline

1 asset

RD Therapeutics Adult Multivitamin

Unknown

Partnerships

Industry-leading partnersregulatory bodiespatient groupsmedical societies

Beyond the preview

Go deeper on RD Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RD Therapeutics.

Explore the full profile